EBrain Scientific

EBrain Scientific was founded in December 2022, jointly established by a Taiwanese technical team and mainland enterprises, and began operations in June 2023. The core technical team has over twenty years of experience in brain-computer interface (BCI) research and development, as well as industrial expertise, and has published more than 40 high-level papers in SCI journals. EBrain Scientific focuses on central nervous system (CNS) diseases, using BCI devices to collect and monitor electroencephalogram (EEG) data as a foundation, while employing digital therapeutics (DTx) and neurofeedback training (NFB) as methods to build a medical-grade brain health digital platform. Centered around this platform, the company is developing its technology and product layout across two main areas—digital health and digital medicine—exploring new application scenarios and operational models to provide optimal solutions for brain-related diseases.